Mirja K. is an experienced professional in cell and gene therapies, currently serving as the Cell Therapies Service Operations Manager and Senior Quality Assurance Manager at the Hudson Institute of Medical Research since July 2016. Responsibilities include leading the establishment of a Quality Management System for Cell Therapy Manufacturing aligned with NATA and TGA regulations. Prior roles encompass Production Manager for Gene and Cell Therapies, overseeing innovative products for Phase 1 Clinical Trials, and a Research Fellow with experience in nephrogenesis and biocatalysis. Mirja K. is also active in multiple committees within the International Society for Cell & Gene Therapy and serves as Vice President and Website Administrator for DerDieDas.org.au, promoting German language opportunities for bilingual children. Academic qualifications include a PhD in Biochemistry and Bioprocess Engineering from Technische Universität Berlin, and a Diplom in Biology from The University of Göttingen.
This person is not in any teams
Hudson Institute of Medical Research
Hudson Institute is a leading Australian medical research institute recognized internationally for discovery science and translational research.